BerGenBio ASA (FRA:7BG0) Short Interest

View and export this data going back to 2019. Start your Free Trial

What is BerGenBio ASA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of BerGenBio ASA's Short Interest

For the Biotechnology subindustry, BerGenBio ASA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BerGenBio ASA's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BerGenBio ASA's Short Interest distribution charts can be found below:

* The bar in red indicates where BerGenBio ASA's Short Interest falls into.

Save Embed

;

Save Embed

;

BerGenBio ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (FRA:7BG0) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

BGBIO:Norway 0RU5:UK

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.

BerGenBio ASA Headlines

No Headlines